Your browser doesn't support javascript.
loading
How to increase awareness of additional vaccinations; the case of maternal pertussis vaccination.
van Zoonen, K; Ruijs, W L M; De Melker, H E; Bongers, M E J; Mollema, L.
Afiliación
  • van Zoonen K; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands. Kim.van.zoonen@rivm.nl.
  • Ruijs WLM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands.
  • De Melker HE; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands.
  • Bongers MEJ; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands.
  • Mollema L; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands.
BMC Public Health ; 21(1): 1257, 2021 06 29.
Article en En | MEDLINE | ID: mdl-34187436
BACKGROUND: Effective and safe vaccines are available outside national immunization programs (NIP). Increased awareness and vaccine uptake can improve public health. Before the inclusion of maternal pertussis vaccination (MPV) in the Dutch NIP in December 2019, extra communication efforts were undertaken. Here we examine the success of these efforts, investigating women's awareness of and their decision-making process regarding MPV. METHODS: Between December 2018 and January 2019, one year before the introduction of MPV in the NIP, and about three years after MPV was recommended by the Dutch Health Council, pregnant and non-pregnant women (i.e. child younger than two years) were invited to fill out an online questionnaire. Participant's decision-making processes regarding MPV were assessed with an adapted Precaution Adoption Process Model (PAPM), including stages of awareness, engagement, information-seeking, and vaccination behaviour. Furthermore, factors related to the decision-making process were examined. RESULTS: In total, 942 women were included, of whom 62% were non-pregnant. Most of the pregnant and nonpregnant women were aware of MPV during pregnancy (respectively 69 and 56%). Most aware women had heard about MPV through their midwife and the Public Health Institute (PHI) website. Women unaware of MPV reported a need for information, preferably from their midwives. Most aware women felt MPV was important to them (88%) and were classified as "engaged". Of the eligible and "engaged" pregnant women, 58% were vaccinated, versus 38% of "engaged" non-pregnant women. CONCLUSIONS: As the most preferred and trusted source of information, midwives are essential to increasing awareness of MPV. The PHI website is considered to be a reliable information source and is often consulted. To increase awareness, appropriate healthcare workers should be encouraged to actively inform target groups about available, additional vaccinations.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Tos Ferina Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Child / Female / Humans / Pregnancy Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Tos Ferina Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Child / Female / Humans / Pregnancy Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos